European Patent Office

T 0844/18 (CRISPR-Cas/BROAD INSTITUTE) of 16.01.2020

European Case Law Identifier
ECLI:EP:BA:2020:T084418.20200116
Date of decision
16 January 2020
Case number
T 0844/18
Petition for review of
-
Application number
13818570.7
IPC class
C12N 15/63
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Engineering of systems, methods and optimized guide compositions for sequence manipulation
Applicant name
The Broad Institute, Inc.
Massachusetts Institute of Technology
President and Fellows of Harvard College
Opponent name
Schlich, George
Grund, Dr., Martin
Regimbeau
CRISPR Therapeutics AG
Storz, Dr. Ulrich
Novozymes A/S
Boxall Intellectual Property Management Limited
Sagittarius Intellectual Property LLP
Adams, Harvey Vaughan John
Board
3.3.08
Headnote
-
Relevant legal provisions
Accord Healthcare -v- Research Corporation Technologies [2017] EWHC 2711 (Ch)European Convention on Human Rights Art. 1 of Protocol No. 1European Patent Convention Art 112(1)(a) (2007)European Patent Convention Art 54(3) (2007)European Patent Convention Art 60(3) (2007)European Patent Convention Art 87(1) (2007)European Patent Convention Art 87(2) (2007)European Patent Convention Art 87(3) (2007)European Patent Convention Art 88(1) (2007)European Patent Convention Art 90(3) (2007)European Patent Convention Art 90(5) (2007)European Patent Convention R 52 (2007)European Patent Convention R 53 (2013)KCI Licensing -v- Smith & Nephew [2010] EWHC 1487 (Pat)Notice from the President of the EPO dated 26 January 1996 concerning priority conferring effect of the "US provisional application for a patent"Paris Convention_Art. 4A, 4A(1), 4A(2), 4A(3), 4D, 4D(1), 4D(4), 4F, 4G, 19PCT_Art. 8(1), 8(2)(a), 8(2)(b)Riendeau -v- Zehnder Group International AG, Swiss Federal Patent Court, 21 March 2018The Constitution of the United States Art. VI, clause 2VCLTIO_Art. 31(1), 33(4)
Keywords
Priority - main request (no)
Novelty - main request (no)
Catchword
i) The board is empowered to and must assess the validity of a priority right claim as required by Article 87(1) EPC,
ii) the board's interpretation of the expression "any person" in Article 87(1) EPC confirms the long-established "all applicants" or the "same applicants" approach,
iii) the national law does not govern who is "any person" as per Article 87(1) EPC, the Paris Convention determines who "any person" is.

Order

For these reasons it is decided that:

The appeal is dismissed.